This company has been marked as potentially delisted and may not be actively trading. Zealand Pharma A/S (ZEAL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial resultsMay 1, 2025 | globenewswire.comZealand Pharma says obesity drug deal with Roche will help it stay independentApril 27, 2025 | ft.comZealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetesApril 24, 2025 | globenewswire.comZealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discoveryApril 23, 2025 | globenewswire.comZealand Pharma launches long-term incentive programs for board of directorsApril 20, 2025 | msn.comTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsApril 19, 2025 | globenewswire.comZealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2025April 19, 2025 | globenewswire.comResolutions from Zealand Pharma's Annual General Meeting 2025March 27, 2025 | globenewswire.comZealand Pharma major shareholder announcement: Van Herk Investments B.V.March 25, 2025 | globenewswire.comZealand Pharma increases its share capital as a result of the exercise of employee warrantsMarch 20, 2025 | globenewswire.comEnrolment concludes in Zealand’s Phase IIb obesity therapy trialMarch 19, 2025 | msn.comRoche’s obesity deal with Zealand Pharma tees up rival for GLP-1sMarch 17, 2025 | finance.yahoo.comZealand Pharma completes enrollment in ZUPREME-1 trialMarch 17, 2025 | markets.businessinsider.comZealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesityMarch 17, 2025 | globenewswire.comNovo Nordisk Stock Slides After Roche Strikes Weight-Loss DealMarch 14, 2025 | wsj.comRoche secures Zealand obesity drug candidate for up to $5.3 billionMarch 12, 2025 | msn.comZealand Pharma upgraded to Buy from Hold at SEB EquitiesMarch 12, 2025 | markets.businessinsider.comRoche shares pop 4% on $5.3 billion obesity drug deal with Zealand PharmaMarch 12, 2025 | msn.comZealand Pharma Shares Leap After Weight-Loss Licensing Deal With RocheMarch 12, 2025 | marketwatch.comZealand and Roche strike $5.3bn obesity treatment dealMarch 12, 2025 | finance.yahoo.comEuropean shares jump on Ukraine ceasefire hopes; Zealand Pharma soarsMarch 12, 2025 | msn.comRoche pairs with Zealand Pharma on obesity drug candidateMarch 12, 2025 | msn.comZealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesityMarch 12, 2025 | globenewswire.comWilliam Blair upgrades Zealand to Outperform on recent selloffMarch 7, 2025 | markets.businessinsider.comZealand Pharma initiated with a Market Perform at William BlairFebruary 28, 2025 | markets.businessinsider.comZealand Pharma price target lowered to DKK 1,050 from DKK 1,080 at BerenbergFebruary 24, 2025 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)February 21, 2025 | markets.businessinsider.comZealand Pharma price target lowered to DKK 750 from DKK 755 at Morgan StanleyFebruary 21, 2025 | markets.businessinsider.comZealand Pharma stock falls loss widens, revenue declinesFebruary 20, 2025 | in.investing.comZealand Pharma steadfastly upholds amylin-based obesity drug strategyFebruary 20, 2025 | finance.yahoo.comZealand Pharma targets 15-20% weight loss with petrelintide trials in 2025February 20, 2025 | msn.comCorrection: Zealand Pharma Announces Financial Results for the Full Year 2024February 20, 2025 | globenewswire.comZealand Pharma Announces Financial Results for the Full Year 2024February 20, 2025 | globenewswire.comZealand CEO on navigating the obesity space among the two biggest playersJanuary 15, 2025 | msn.comTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsJanuary 13, 2025 | globenewswire.comSteven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in ObesityJanuary 7, 2025 | globenewswire.comZealand Pharma price target lowered to DKK 750 from DKK 815 at Deutsche BankJanuary 6, 2025 | markets.businessinsider.comZealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13thJanuary 6, 2025 | globenewswire.comTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsDecember 25, 2024 | globenewswire.comZealand Pharma major shareholder announcement: The Capital Group Companies, Inc.December 25, 2024 | globenewswire.comZealand Pharma Falls Short of FDA Approval for GlepaglutideDecember 21, 2024 | marketwatch.comFDA drug rejection hits Zealand Pharma sharesDecember 20, 2024 | ft.comU.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndromeDecember 19, 2024 | globenewswire.comZealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesityDecember 10, 2024 | globenewswire.comZealand Pharma to participate in the Jefferies London Healthcare ConferenceNovember 13, 2024 | globenewswire.comTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsNovember 11, 2024 | globenewswire.comA new weight loss drug could beat Ozempic's side effect problemNovember 6, 2024 | yahoo.comEarnings To Watch: Zealand Pharma AS (OCSE:ZEAL) Reports Q3 2024 ResultNovember 6, 2024 | finance.yahoo.comZealand’s Weight-Loss Drug Has Minimal Side Effects in StudyNovember 5, 2024 | bloomberg.comNext-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO saysOctober 12, 2024 | msn.com Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address ZEAL Media Mentions By Week ZEAL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZEAL News Sentiment▼1.080.72▲Average Medical News Sentiment ZEAL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZEAL Articles This Week▼12▲ZEAL Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viking Therapeutics News Today Crinetics Pharmaceuticals News Today Merus News Today Catalyst Pharmaceuticals News Today Xenon Pharmaceuticals News Today MorphoSys News Today Protagonist Therapeutics News Today HUTCHMED News Today MoonLake Immunotherapeutics News Today Metsera News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZEAL) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZEAL Stock Free ZEAL Stock Alerts